Sector Update: Health Care Stocks Declining This Afternoon
3:53PM ET 1/24/2022 MT NewswiresHealth care stocks were sliding this afternoon, with the NYSE Health Care Index falling 2.1% while the SPDR Health Care Select Sector ETF (XLV) was...
Quotes Snapshot > AIKI
Aikido Pharma Inc AIKI:NASDAQ
Last Price$0.48NASDAQ Closing Price as of 4:00PM ET 1/27/22
NASDAQ 15-minute delayed Bid/Ask Quotes
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.03(6.05%)
Bid (Size)$0.48 (5)
Ask (Size)$0.48 (18)
Day Low / High$0.47 - 0.51
Volume759.9 K
Read more news Recent News
Sector Update: Health Care
3:31PM ET 1/24/2022 MT NewswiresHealth care stocks continued to sputter this afternoon, with the NYSE Health Care Index falling 2.1% and the SPDR Health Care Select Sector ETF (XLV) down...
AIkido Pharma's Board Authorizes Stock Buyback Program
2:08PM ET 1/24/2022 MT NewswiresThe board of AIkido Pharma (AIKI) authorized the company to repurchase up to $3 million of the company's common stock, effective immediately. The shares...
AIkido Pharma Gets Equity Interest in ASP Isotopes
1:48PM ET 12/06/2021 MT NewswiresAIkido Pharma (AIKI) said Monday it has secured a "strategic" equity stake in ASP Isotopes, a supplier of non-nuclear enriched isotopes, for an undisclosed...
View all Commentary and Analysis
No news stories available at this time.
Company Profile
Business DescriptionAIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY. View company web site for more details
| Address | One Rockefeller Plaza New York, New York 10020 |
| Phone | +1.12.745.1374 |
| Number of Employees | 6 |
| Recent SEC Filing | 01/24/2022 8-K |
| CEO, Chief Financial Officer & Director | Anthony C. Hayes |
Company Highlights
| Price Open | $0.51 |
| Previous Close | $0.51 |
| 52 Week Range | $0.42 - 2.55 |
| Market Capitalization | $42.9 M |
| Shares Outstanding | 89.7 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 03/24/2022 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | N/A |
| Earnings per Share | -$0.08 |
| Beta vs. S&P 500 | N/A |
| Revenue | $28.0 K |
| Net Profit Margin | N/A |
| Return on Equity | -5.92% |
Analyst Ratings as of 10/08/2021
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |